In our study, the novel frameshift mutation (c.668delA/p.N223TfsX19) may lead to functional haploinsufficiency of FLCN, which may fail to regulate mTOR activity and lead to BHD. This evidence concerns the gene MTOR and Birt-Hogg-Dube syndrome.